Alimera Sciences To Release Second Quarter 2014 Results

           Alimera Sciences To Release Second Quarter 2014 Results  PR Newswire  ATLANTA, July 24, 2014  ATLANTA, July 24, 2014 /PRNewswire/ --Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter of fiscal year 2014 financial results after the market close on Thursday, August 7, 2014. An investor conference call will follow on the same day at 4:30 p.m. ET.  The conference call will be hosted by Dan Myers, President and Chief Executive Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial Officer.  To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at http://www.alimerasciences.com.  A replay of the conference call will be available beginning August 7, 2014 at 7:30 p.m. ET and ending on August 14, 2014 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 77034836. A replay of the webcast will also be available on the corporate website.  About Alimera Sciences, Inc.  Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its wholly-owned subsidiary, Alimera Sciences Limited.  Investor Contact: ICR, LLC John Mills 310-954-1105 John.Mills@icrinc.com  SOURCE Alimera Sciences, Inc.  Website: http://www.alimerasciences.com  
Press spacebar to pause and continue. Press esc to stop.